Researchers from the UNSW Graduate School of Biomedical Engineering, Ludwig Maximilians University, Case Western Reserve University, and the Cleveland Clinic have identified a source of autologous [the patient’s own] stem cells, called periosteum-derived stem cells [PDSC], which reside in the discarded tissue resulting from hip replacement surgery.
The researchers recommend patients save their own stem cells to be utilized in future regenerative therapies to treat disease, trauma and injury. Early indications are that the PDSC’s may represent a viable source of bankable stem cells for those undergoing hip surgery. However, patients not undergoing hip surgery can still follow the ‘doctor’s orders’ to bank your own, valuable stem cells by banking the mesenchymal stem cells found in teeth. The stem cells can be recovered easily and non-invasively during routine dental procedures.
Orthopedics is an area where there is intense research underway to replace current, invasive medical strategies with non-invasive, regenerative stem cell therapies that take advantage of the body’s ability to repair and maintain itself. Hence, stem cell treatments may reduce and perhaps eliminate the need for most hip surgeries in the not too distant future and, in an interesting twist, reduce the opportunities to bank stem cells from the discarded tissue following surgery.
To learn more about the value of preserving your own stem cells for use in future regenerative therapies and how to bank your own dental pulp stem cells through a non-evasive and affordable method, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.